Aptamer for ADAMTS5 and use for aptamer for ADAMTS5
US11473089B2 · kind B2 · utility
0Cited by
0References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 9, 2018 |
| Grant date | Oct 18, 2022 |
| Priority date | — |
| Expiry date | Nov 9, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/96486
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an aptamer containing a sequence shown by the following formula (1) or formula (2): wherein N1 shows 3 to 24 bases in length, Y is C or U, and W is A or U (uracil is optionally thymine), wherein the aptamer binds to a disintegrin and metalloproteinase with thrombospondin motifs-5 (ADAMTS5).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.